Evaluation of Ocular Comfort With ISTA Tears vs Systane
Sponsor: Bausch & Lomb Incorporated
Listed as NCT01650584, this NA trial focuses on Dry Eye Disease and remains completed. Sponsored by Bausch & Lomb Incorporated, it has been updated 11 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Nov 2024 — Present [monthly]
Completed NA
-
Sep 2024 — Nov 2024 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
-
Dec 2019 — Nov 2020 [monthly]
Completed NA
-
Jun 2018 — Dec 2019 [monthly]
Completed NA
-
Jun 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Jun 2017 [monthly]
Completed NA
First recorded
Jun 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bausch & Lomb Incorporated
For direct contact, visit the study record on ClinicalTrials.gov .